Trial
NCT02267317
The Effect of TLR4 Inhibition in Obese and Type 2 Diabetic Subjects
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
The University of Texas Health Science Center at San Antonio
Collaborators
—
Condition
Insulin Sensitivity
Intervention
Eritoran
Why stopped
Study drug expired
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-03-04